Estudo de fase 2b | Imunização contra o vírus sincicial respiratório durante a gestação.
29 Abr, 2022 | 14:53hPrefusion F Protein–Based Respiratory Syncytial Virus Immunization in Pregnancy – New England Journal of Medicine (link para o resumo – $ para o texto completo)
Comentário: RSV Prefusion F Protein-Based Immunization Studied in Pregnancy – HealthDay
Comentário no Twitter
In pregnant women, RSVpreF vaccine elicited neutralizing antibody responses with efficient transplacental transfer and without evident safety concerns. https://t.co/r8oktZmBZQ pic.twitter.com/UE7ffxYJW6
— NEJM (@NEJM) April 27, 2022


